Summary
- Current Price
- As of today, EVMN price is $26.46, up +5.44% in the most recent trading session on
- Current Price All-Time High
- EVMN price is currently -20.32% below its historical high of $33.20 set on
- Market Cap
- EVMN current market cap is $834M, with unknown 1-year change
- PE Ratio
- EVMN PE ratio is unknown
- Revenue
- EVMN current annual revenue is $7.00M, up +40.00% year-over-year
- Next Earnings
- As of today, the next earnings release for EVMN has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Evommune, Inc. |
| Ticker | NYSE: EVMN |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | evommune.com |
| Employees | 45 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $26.46 | |
| Price, 1D Change | +5.44% | |
| $834M | ||
| - | ||
| - | ||
| 1.67 | ||
| $7M | ||
| Revenue, 1Y Change | +40.00% | |
| -$2.27 | ||
| EPS, 1Y Change | -100.59% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | N/A | |
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.27 | ||
| EPS Estimate | N/A | -$6.40 |
| EPS Est. Change | N/A | -181.95% |
| $7.00M | ||
| Revenue Estimate | N/A | $14.43M |
| Revenue Est. Change | N/A | +106.12% |
| Current Price | $26.46 | |
| Price Target | - | $53.00 |
| Price Tgt. Change | - | +100.34% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$6.40 | N/A | - | |
| -$2.67 | N/A | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $14.43M | N/A | - | |
| $9.62M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $26.46 | |
| $20.63 | ||
| SMA 200 vs Price | -22.01% | |
| $21.60 | ||
| SMA 50 vs Price | -18.35% | |
| 1.67 | ||
| $2.87 | ||
| 51.15 | ||
| 84.98% | ||
| 162.99% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $7.00M | ||
| -$2.27 | ||
| $5.71M | ||
| 81.61% | ||
| -$70.01M | ||
| -1,000.19% | ||
| -$66.81M | ||
| -954.40% | ||
| -$68.73M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -1.34 | ||
| 2.64 | ||
| 2.64 | ||
| - | ||
| - | ||
| -2.75 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 64.15 | ||
| -4.55 | ||
| -14.23 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$144.24M | ||
| $72.04M | ||
| $76.06M | ||
| $73.99M | ||
| $220.29M | ||
| $27.98M | ||
| $193.31M | ||
| $1.02M | ||
| $8.26M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $73.81M | ||
| $75.73M | ||
| $1.29M | ||
| $12.77M | ||
| $1.29M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$58.20M | ||
| -$3.99M | ||
| $49.42M | ||
| $88.00K | ||
| -$58.28M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| Oppenheimer | ||
| Raymond James | ||
| HC Wainwright & Co. | ||
| William Blair | ||
| Morgan Stanley | ||
| Leerink Partners | ||
| Evercore ISI Group | ||
| Cantor Fitzgerald |
Analyst sentiment
Institutional ownership
Screeners with EVMN
FAQ
What is the ticker symbol for Evommune, Inc.?
The ticker symbol for Evommune, Inc. is NYSE:EVMN
Does Evommune, Inc. pay dividends?
No, Evommune, Inc. does not pay dividends
What sector is Evommune, Inc. in?
Evommune, Inc. is in the Healthcare sector
What industry is Evommune, Inc. in?
Evommune, Inc. is in the Biotechnology industry
What country is Evommune, Inc. based in?
Evommune, Inc. is headquartered in United States
When did Evommune, Inc. go public?
Evommune, Inc. initial public offering (IPO) was on November 6, 2025
Is Evommune, Inc. in the S&P 500?
No, Evommune, Inc. is not included in the S&P 500 index
Is Evommune, Inc. in the NASDAQ 100?
No, Evommune, Inc. is not included in the NASDAQ 100 index
Is Evommune, Inc. in the Dow Jones?
No, Evommune, Inc. is not included in the Dow Jones index
When does Evommune, Inc. report earnings?
The date for Evommune, Inc.'s next earnings report has not been announced yet
Data Sources & References
- EVMN Official Website www.evommune.com
- EVMN Profile on Yahoo Finance finance.yahoo.com/quote/EVMN
- EVMN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/evmn